Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Influenza

Free Subscription Articles published in J Immunol Retrieve available abstracts of 74 articles: HTML format

Single Articles

February 2026
1. CONDE L, Oliveira DL, Maciel G, Castro F, et al
   Highly efficient and low-cost single-cell culture platform for unbiased analysis of human memory B cell repertoire and antibody discovery.
   J Immunol. 2026;215:vkaf305.
   PubMed     Abstract available
   
   
   
2. APPS R, Polanco JJ, Lowman KE, Wang L, et al
   Leveraging optimized oligonucleotide-tagged antigen assemblies and single-cell sequencing for multiplexed proteogenomic profiling of human B cell reactivities.
   J Immunol. 2026;215:vkaf301.
   PubMed     Abstract available
   
   
   
3. WERNINGHAUS IC, Hinke DM, Katta K, Bogen B, et al
   A combinatorial DNA vaccine encoding APC-targeted, bivalent HA and NA antigens results in an improved influenza vaccine.
   J Immunol. 2026;215:vkaf378.
   PubMed     Abstract available
   
   
   
4. SHARMA SB, Kumar K, Parchment N, Eggleston T, et al
   Viral-specific induction of cellular and soluble urokinase plasminogen activator receptor (suPAR) expression.
   J Immunol. 2026;215:vkaf365.
   PubMed     Abstract available
   
   
   
5. SOUDANI N, Sidney J, Da Silva Antunes R, Case JB, et al
   Identification of immunodominant T cell epitopes in SARS-CoV-2 spike protein in Syrian hamsters.
   J Immunol. 2026;215:vkaf342.
   PubMed     Abstract available
   
   
   December 2025
6. LOPEZ ZAPANA PA, Shook LL, Joughin BA, Jasset OJ, et al
   Maternal proteome profiling reveals dynamic gestational age-specific responses to de novo vaccination.
   J Immunol. 2025 Dec 12:vkaf298. doi: 10.1093.
   PubMed     Abstract available
   
   
   
7. ALBE JR, Chaudhary A, Khanna A, Weinstein K, et al
   Divergent effects of a Treg-selective IL-2 mutein on influenza-specific T cell responses.
   J Immunol. 2025 Dec 10:vkaf297. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. ABE K, Holmes TH, Nguyen TT, Kim-Schulze S, et al
   Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study.
   J Immunol. 2025;214:3310-3320.
   PubMed     Abstract available
   
   
   
9. OSUAGWU AE, Payne M, Bosch J, Mbonye U, et al
   Non-neutralizing antibodies against SARS-CoV-2 nucleocapsid protein mediate variant transcendent antibody-dependent cellular cytotoxicity.
   J Immunol. 2025;214:3385-3398.
   PubMed     Abstract available
   
   
   
10. CHEN Y, Szelinski F, Ferreira-Gomes M, Durek P, et al
    Distinct expression of CD56 and CD19 marks molecular and functional endotypes of tetanus- versus RBD-specific human bone marrow plasma cells.
    J Immunol. 2025;214:3453-3464.
    PubMed     Abstract available
    
    
    October 2025
11. DEVITO L, Mohanraj OS, Debnath D, Constantinesco NJ, et al
    Influenza infection exacerbates high-fat diet-induced atherosclerosis in apolipoprotein gene-deficient mice.
    J Immunol. 2025 Oct 30:vkaf276. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. SILVA-MORAES V, Reis LR, Ross TM
    Comparative analysis of cellular immune responses to four seasonal inactivated influenza vaccines in younger and older adults.
    J Immunol. 2025 Oct 30:vkaf286. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. BRADLEY MC, Aliyu T, Gray J, Guan T, et al
    Dietary iron deficiency impairs effector function of memory T cells following influenza infection.
    J Immunol. 2025 Oct 29:vkaf291. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2025
14. BYRNE J, Gaillard CM, Gu L, Garcia-Leon A, et al
    Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contacts.
    J Immunol. 2025;214:2238-2243.
    PubMed     Abstract available
    
    
    August 2025
15. FENG Z, Han S, He Q, Zhao H, et al
    Chemokine (C-X-C motif) ligand 11 is a crucial antiviral modulator that affects viral replication, the IFN-gamma response, and T-cell functions during respiratory syncytial virus infection.
    J Immunol. 2025;214:1982-1999.
    PubMed     Abstract available
    
    
    July 2025
16. AGRAFIOTIS A, Kuhn R, Panetti C, Venerito M, et al
    Clonally expanded IgG, but not IgA, antibody-secreting cells preferentially target influenza nucleoprotein following homologous and heterologous infections.
    J Immunol. 2025 Jul 26:vkaf144. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2025
17. YANG OO
    The immunopathogenesis of SARS-CoV-2 infection: Overview of lessons learned in the first 5 years.
    J Immunol. 2025;214:1095-1104.
    PubMed     Abstract available
    
    
    May 2025
18. ALLEN JD, Medina JM, Thomas MH, Lynch A, et al
    H3 hemagglutinin proteins optimized for 2018 to 2022 elicit neutralizing antibodies across panels of modern influenza A(H3N2) viruses.
    J Immunol. 2025 May 21:vkaf092. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. NOURI HR, Schaunaman N, Kraft M, Numata M, et al
    Tollip deficiency enhances mitophagy and reduces STING activation in influenza A virus-infected mice.
    J Immunol. 2025 May 16:vkaf058. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2025
20. MADRID DMC, Gu W, Karim SJI, Lowke MT, et al
    Single-cell analysis of pig lung leukocytes and their response to influenza infection and oseltamivir therapy.
    J Immunol. 2025 Apr 15:vkaf032. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. DING C, Chen Q, Shi Y, Liu J, et al
    Impact of CD4+ T cell and TCR repertoires on SARS-CoV-2-Specific antibody responses in PLWH following COVID-19 vaccination.
    J Immunol. 2025 Apr 15:vkae040. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. HATIPOGLU I, Ainsua-Enrich E, Kadel S, Turner S, et al
    IRF4-regulated transcriptional and functional heterogeneity of lung-resident CD11b+ cDC2 subsets during influenza virus infection.
    J Immunol. 2025 Apr 10:vkaf060. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. DINANT S, Castille J, Deloizy C, Bruder E, et al
    The prion-family protein Doppel exerts a protective role during influenza virus infection.
    J Immunol. 2025 Apr 9:vkaf031. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2025
24. RAO AS, Ugwu N, Onufer AP, Kumova O, et al
    Cathelicidin-related antimicrobial peptide (CRAMP) is toxic during neonatal murine influenza virus infection.
    J Immunol. 2025 Mar 18:vkae053. doi: 10.1093.
    PubMed     Abstract available
    
    
    
25. KHAN R, Ji W, Guzman Rivera J, Madhvi A, et al
    A genetically modulated Toll-like receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome.
    J Immunol. 2025;214:373-383.
    PubMed     Abstract available
    
    
    
26. BURMAS L, Lee WS, Kelly A, Webster R, et al
    Modulation of germinal center and antibody dynamics via ipsilateral versus contralateral immunization against SARS-CoV-2.
    J Immunol. 2025;214:335-346.
    PubMed     Abstract available
    
    
    February 2025
27. WANG M, Liu C, Fan Q, Sun Y, et al
    Rapid clonal expansion and somatic hypermutation contribute to the fate of SARS-CoV-2 broadly neutralizing antibodies.
    J Immunol. 2025;214:278-289.
    PubMed     Abstract available
    
    
    January 2025
28. GROVENSTEIN P, Bhatnagar N, Kim KH, Pal SS, et al
    Influenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and significantly enhances the efficacy of inactivated split vaccination when coadministered.
    J Immunol. 2025;214:104-114.
    PubMed     Abstract available
    
    
    
29. QIAO P, Yue C, Peng W, Liu K, et al
    Precise motif and cross-presentation of coronavirus peptides by feline MHC class I: implications for the mild infection of SARS-CoV-2.
    J Immunol. 2025;214:115-129.
    PubMed     Abstract available
    
    
    November 2024
30. TONG X, Deng Y, Cizmeci D, Fontana L, et al
    Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination.
    J Immunol. 2024 Nov 17:ji2200956. doi: 10.4049/jimmunol.2200956.
    PubMed     Abstract available
    
    
    
31. DICK JK, Sangala JA, Krishna VD, Khaimraj A, et al
    NK Cell and Monocyte Dysfunction in Multisystem Inflammatory Syndrome in Children.
    J Immunol. 2024;213:1452-1466.
    PubMed     Abstract available
    
    
    October 2024
32. RAJU N, Kramer KJ, Cavallaro M, Diotti RA, et al
    Multiplexed Antibody Sequencing and Profiling of the Human Hemagglutinin-specific Memory B Cell Response following Influenza Vaccination.
    J Immunol. 2024 Oct 23:ji2400326. doi: 10.4049/jimmunol.2400326.
    PubMed     Abstract available
    
    
    September 2024
33. DRUSKOVIC M, Lucovnik M, Mesaric VA, Kavsek G, et al
    Immune Response to SARS-CoV-2 in Vaccine-naive Pregnant Women: Assessment of IgG and IgA Antibody Profile at Delivery and 42 Days Postpartum.
    J Immunol. 2024 Sep 11:ji2400055. doi: 10.4049/jimmunol.2400055.
    PubMed     Abstract available
    
    
    
34. HOLDER KA, Ings DP, Fifield KE, Barnes DA, et al
    Sequence Matters: Primary COVID-19 Vaccination after Infection Elicits Similar Anti-spike Antibody Levels, but Stronger Antibody Dependent Cell-mediated Cytotoxicity than Breakthrough Infection.
    J Immunol. 2024 Sep 9:ji2400250. doi: 10.4049/jimmunol.2400250.
    PubMed     Abstract available
    
    
    
35. IZADI A, Godzwon M, Soderlund Strand A, Schmidt T, et al
    Protective Non-neutralizing anti-N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence.
    J Immunol. 2024;213:678-689.
    PubMed     Abstract available
    
    
    June 2024
36. HE Z, Li W, Zhang M, Huang M, et al
    RNF216 Inhibits the Replication of H5N1 Avian Influenza Virus and Regulates the RIG-I Signaling Pathway in Ducks.
    J Immunol. 2024 Jun 3:ji2300540. doi: 10.4049/jimmunol.2300540.
    PubMed     Abstract available
    
    
    
37. LEIGHTON PA, Ching K, Reynolds K, Vuong CN, et al
    Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies.
    J Immunol. 2024;212:1744-1753.
    PubMed     Abstract available
    
    
    
38. LEE MJ, de Los Rios Kobara I, Barnard TR, Vales Torres X, et al
    NK Cell-Monocyte Cross-talk Underlies NK Cell Activation in Severe COVID-19.
    J Immunol. 2024;212:1693-1705.
    PubMed     Abstract available
    
    
    May 2024
39. BOUCHER J, Gilbert C, Bose S, Tessier PA, et al
    S100A9: The Unusual Suspect Connecting Viral Infection and Inflammation.
    J Immunol. 2024;212:1523-1529.
    PubMed     Abstract available
    
    
    
40. SAITO S, Bozorgmehr N, Sligl W, Osman M, et al
    The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2-Infected Individuals with Severe Disease.
    J Immunol. 2024;212:1540-1552.
    PubMed     Abstract available
    
    
    April 2024
41. BUDYLOWSKI P, Chau SLL, Banerjee A, Guvenc F, et al
    A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera.
    J Immunol. 2024 Apr 29:ji2300320. doi: 10.4049/jimmunol.2300320.
    PubMed     Abstract available
    
    
    
42. KUNDURA L, Cezar R, Ballongue E, Andre S, et al
    Low Percentage of Perforin-Expressing NK Cells during Severe SARS-CoV-2 Infection: Consumption Rather than Primary Deficiency.
    J Immunol. 2024;212:1105-1112.
    PubMed     Abstract available
    
    
    
43. ABE K, Beer JC, Nguyen T, Ariyapala IS, et al
    Cross-Platform Comparison of Highly Sensitive Immunoassays for Inflammatory Markers in a COVID-19 Cohort.
    J Immunol. 2024;212:1244-1253.
    PubMed     Abstract available
    
    
    March 2024
44. LI W, Lin Y, Wang X, Yang H, et al
    Chicken UFL1 Restricts Avian Influenza Virus Replication by Disrupting the Viral Polymerase Complex and Facilitating Type I IFN Production.
    J Immunol. 2024 Mar 13:ji2300613. doi: 10.4049/jimmunol.2300613.
    PubMed     Abstract available
    
    
    
45. READ KA, Amici SA, Farsi S, Cutcliffe M, et al
    PRMT5 Promotes T follicular helper Cell Differentiation and Germinal Center Responses during Influenza Virus Infection.
    J Immunol. 2024 Mar 4:ji2300270. doi: 10.4049/jimmunol.2300270.
    PubMed     Abstract available
    
    
    
46. AL-AHMAD A
    Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
    J Immunol. 2024;212:753.
    PubMed    
    
    
    
47. MAINO A, Amen A, Plumas J, Bouquet L, et al
    Development of a New Off-the-Shelf Plasmacytoid Dendritic Cell-Based Approach for the Expansion and Characterization of SARS-CoV-2-Specific T Cells.
    J Immunol. 2024;212:825-833.
    PubMed     Abstract available
    
    
    February 2024
48. TANDON P, Abrams ND, Avula LR, Carrick DM, et al
    Unraveling Links between Chronic Inflammation and Long COVID: Workshop Report.
    J Immunol. 2024;212:505-512.
    PubMed     Abstract available
    
    
    
49. BRADSHAW CM, Georgieva T, Tankersley TN, Taylor-Doyle T, et al
    Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection.
    J Immunol. 2024;212:523-528.
    PubMed     Abstract available
    
    
    
50. DHANUSHKODI NR, Prakash S, Quadiri A, Zayou L, et al
    Antiviral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models.
    J Immunol. 2024;212:576-585.
    PubMed     Abstract available
    
    
    
51. KAMMANN T, Gorin JB, Parrot T, Gao Y, et al
    Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional Anomalies.
    J Immunol. 2024;212:389-396.
    PubMed     Abstract available
    
    
    November 2023
52. LOBBY JL, Danzy S, Holmes KE, Lowen AC, et al
    Both Humoral and Cellular Immunity Limit the Ability of Live Attenuated Influenza Vaccines to Promote T Cell Responses.
    J Immunol. 2023 Nov 20:ji2300343. doi: 10.4049/jimmunol.2300343.
    PubMed     Abstract available
    
    
    
53. EVANS JP, Liu SL
    Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies.
    J Immunol. 2023;211:1459-1467.
    PubMed     Abstract available
    
    
    October 2023
54. MA W, Loving CL, Driver JP
    From Snoot to Tail: A Brief Review of Influenza Virus Infection and Immunity in Pigs.
    J Immunol. 2023;211:1187-1194.
    PubMed     Abstract available
    
    
    
55. DIAZ FE, McGill JL
    Modeling Human Respiratory Syncytial Virus (RSV) Infection: Recent Contributions and Future Directions Using the Calf Model of Bovine RSV Disease.
    J Immunol. 2023;211:1180-1186.
    PubMed     Abstract available
    
    
    
56. NOORUZZAMAN M, Diel DG
    Infection Dynamics, Pathogenesis, and Immunity to SARS-CoV-2 in Naturally Susceptible Animal Species.
    J Immunol. 2023;211:1195-1201.
    PubMed     Abstract available
    
    
    
57. ROSENBERG-HASSON Y, Holmes TH, Diray-Arce J, Chen J, et al
    Relationship of Heterologous Virus Responses and Outcomes in Hospitalized COVID-19 Patients.
    J Immunol. 2023;211:1224-1231.
    PubMed     Abstract available
    
    
    September 2023
58. LUCKE J, Heinrich F, Malsy J, Meins N, et al
    Intestinal IL-1beta Plays a Role in Protecting against SARS-CoV-2 Infection.
    J Immunol. 2023;211:1052-1061.
    PubMed     Abstract available
    
    
    August 2023
59. SANDBERG JK, Leeansyah E, Eller MA, Shacklett BL, et al
    The Emerging Role of MAIT Cell Responses in Viral Infections.
    J Immunol. 2023;211:511-517.
    PubMed     Abstract available
    
    
    
60. CAO L, Hui X, Xu T, Mao H, et al
    The RNA-Splicing Ligase RTCB Promotes Influenza A Virus Replication by Suppressing Innate Immunity via Interaction with RNA Helicase DDX1.
    J Immunol. 2023 Aug 9:ji2200799. doi: 10.4049/jimmunol.2200799.
    PubMed     Abstract available
    
    
    July 2023
61. YU H, Worrall LJ, Berger T, Petric M, et al
    Identification of an optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2.
    J Immunol. 2023 Jul 26:ji2300282. doi: 10.4049/jimmunol.2300282.
    PubMed     Abstract available
    
    
    
62. LAW JC, Watts TH
    Considerations for Choosing T Cell Assays during a Pandemic.
    J Immunol. 2023;211:169-174.
    PubMed     Abstract available
    
    
    
63. PONDE NO, Shoger KE, Khatun MS, Sarkar MK, et al
    SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor.
    J Immunol. 2023;211:252-260.
    PubMed     Abstract available
    
    
    June 2023
64. CHEUNG MW, Dayam RM, Shapiro JR, Law JC, et al
    Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.
    J Immunol. 2023 Jun 16:ji2300190. doi: 10.4049/jimmunol.2300190.
    PubMed     Abstract available
    
    
    
65. MAMBELLI F, Marinho FV, Andrade JM, de Araujo ACVSC, et al
    Recombinant Bacillus Calmette-Guerin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge.
    J Immunol. 2023;210:1925-1937.
    PubMed     Abstract available
    
    
    
66. PAIDI RK, Jana M, Raha S, Mishra RK, et al
    Prenol, but Not Vitamin C, of Fruit Binds to SARS-CoV-2 Spike S1 to Inhibit Viral Entry: Implications for COVID-19.
    J Immunol. 2023;210:1938-1949.
    PubMed     Abstract available
    
    
    
67. NAM H, Koh JY, Jung JH, Jeong H, et al
    Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19.
    J Immunol. 2023;210:1687-1699.
    PubMed     Abstract available
    
    
    May 2023
68. PHAN JM, Layton ED, Yu KKQ, Aguilar MS, et al
    Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2.
    J Immunol. 2023;210:1236-1246.
    PubMed     Abstract available
    
    
    March 2023
69. FINN CM, Dhume K, Prokop E, Strutt TM, et al
    STAT1 Controls the Functionality of Influenza-Primed CD4 T Cells but Therapeutic STAT4 Engagement Maximizes Their Antiviral Impact.
    J Immunol. 2023 Mar 24:ji2200407. doi: 10.4049/jimmunol.2200407.
    PubMed     Abstract available
    
    
    
70. HEMANN EA, Knoll ML, Wilkins CR, Subra C, et al
    A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.
    J Immunol. 2023 Mar 20:ji2300026. doi: 10.4049/jimmunol.2300026.
    PubMed     Abstract available
    
    
    
71. VAN DE WALL S, Crooks S, Varga SM, Badovinac VP, et al
    Cutting Edge: Influenza-Induced CD11alo Airway CD103+ Tissue Resident Memory T Cells Exhibit Compromised IFN-gamma Production after In Vivo TCR Stimulation.
    J Immunol. 2023 Mar 13:ji2200931. doi: 10.4049/jimmunol.2200931.
    PubMed     Abstract available
    
    
    
72. ZHAO Y, Xiao W, Wu Y, Fan W, et al
    Parallel T Cell Immunogenic Regions in Influenza B and A Viruses with Distinct Nuclear Export Signal Functions: The Balance between Viral Life Cycle and Immune Escape.
    J Immunol. 2023 Mar 10:ji2200243. doi: 10.4049/jimmunol.2200243.
    PubMed     Abstract available
    
    
    
73. SHAMSELDIN MM, Kenney A, Zani A, Evans JP, et al
    Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.
    J Immunol. 2023 Mar 6:ji2200297. doi: 10.4049/jimmunol.2200297.
    PubMed     Abstract available
    
    
    February 2023
74. QUINN M, Parra-Rodriguez L, Alsoussi WB, Ayres C, et al
    Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination.
    J Immunol. 2023 Feb 13:ji2200920. doi: 10.4049/jimmunol.2200920.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum